Polaryx Therapeutics IPO: Rare Disease Biotech Set for Nasdaq Listing
US-based biotechnology company Polaryx Therapeutics is preparing to enter the stock market through a direct listing on the…
Aktis Oncology IPO 2026: Nasdaq Launch & Cancer Therapy Update
Aktis Oncology, Inc., a leading U.S.-based biotech company, is set to go public on the Nasdaq through its…


































































